Initial Herpes Zoster Treatment


The symptoms of herpes zoster are generally localised pain involving sensory nerves, fever, and headache. Lymph nodes draining the affected area usually become enlarged. Blistering rash develops in the affected area and starts as red papules. Blisters continue to erupt for several days, crust over, and become pustular. The affected person may also experience other symptoms such as fever and headache.
Treatment with oral antivirals

Antiviral drugs are commonly used for the initial treatment of herpes zoster. They have been proven effective for treating HZO in many cases, especially in those who have not developed complications from previous infections. However, some antivirals may not work as well as they should. This article will discuss the effectiveness of oral antiviral medication in treating herpes zoster.

Acyclovir is an effective oral antiviral that is usually used for treating initial and recurrent herpes zoster. It suppresses the outbreak of herpes zoster in immunocompetent and immunocompromised patients. It is not effective against the Epstein-Barr virus, but is safe to use at low doses. Acyclovir must be taken at least 48 hours before the onset of the first symptoms of herpes zoster.

Acyclovir is available as tablets, liquids, and delayed-release buccal tablets. Delayed-release buccal tablets are applied to the upper gum in the mouth. Both forms of the medicine are taken orally two to five times per day. The treatment course may last for several days, or even a few months. However, if you are not immune-compromised, oral valacyclovir should not be used as the initial treatment for herpes zoster.

Treatment with shingles vaccine

Getting the shingles vaccine is one of the most common ways to prevent future outbreaks of herpes zoster. It is 90% effective at preventing the disease. Shingles is a painful skin rash that can lead to PHN, or post-herpetic neuralgia, which causes burning pain. This condition often occurs in older people. In order to avoid PHN, you should receive the vaccine at least two weeks before contracting the disease.

Although herpes zoster is contagious, it is not life-threatening. People are usually not aware that they have contracted the disease. However, many adults have experienced chickenpox at some point in their lives. The shingles virus is caused by the same virus that causes chickenpox. It can remain dormant in the body for years before becoming active and causing a painful outbreak. Vaccination with the shingles vaccine is recommended for healthy adults over 50, as well as those with compromised immune systems. Adults who have had chickenpox are also recommended for the vaccination. Vaccination is also recommended for children.

Treatment with topical antivirals

Initially, herpes zoster patients are treated with acyclovir, an antiviral cream. It is applied to the affected area of the skin, and it should help alleviate the symptoms of the disease. However, the topical antiviral should not be applied to unaffected skin or to genital herpes sores. These treatments are only effective when started within 72 hours of the onset of the rash.

In addition to topical antivirals, doctors may prescribe oral acyclovir, a cream that is applied to the affected area to reduce pain and inflammation. In some cases, the symptoms of herpes zoster may last longer than the rash, and patients may also need narcotics or anticonvulsants to control the pain. Nevertheless, initial herpes zoster treatment with topical antivirals is effective for most cases, but there is a small percentage of cases where it fails.

Treatment with topical cyclosporine

Topical cyclosporine, which is a potent immunosuppressive drug, is used in the treatment of autoimmune skin diseases, rheumatology, ophthalmology, and organ transplantation. Although there are few studies that support cyclosporine’s antiviral properties, there are a few case reports that point to its beneficial effects on the disease course.

Topical cyclosporine is available in the form of a tablet, liquid, and delayed-release buccal tablet. The latter is applied to the upper gum of the mouth. Topical cyclosporine is typically taken two to five times daily. It can also be given intravenously. This medication is considered effective in reducing the duration and severity of post-herpetic neuralgia.

Among these patients, those who had been treated with topical cyclosporine experienced a lower recurrence rate than those who had not received the drug. Additionally, patients who had thermal cautery before the drug was applied showed lower rates of HSK recurrences. The effect of topical cyclosporine on the ocular surface was also noted in the study of patients who had prior treatment.